NeuroPro Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch NeuroPro Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042 (NCT07222878) | NeuroPro Therapeutics, Inc. | 2025-09-29 |
| A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures (NCT06769659) | NeuroPro Therapeutics, Inc. | 2025-03-11 |
| A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042 (NCT06525649) | NeuroPro Therapeutics, Inc. | 2024-08-21 |
| Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects (NCT05503511) | NeuroPro Therapeutics, Inc. | 2022-10-20 |
Track NeuroPro Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.